65173002RM017L0
Start: 1 August 2022
End: 31 July 2023
Conducting Research - 43%
Viewer: 991
Publish date6 September 2022 06:39
Policy Brief Issue 31: Strategies for Sustainable Access: Unpacking Managed Entry Agreements (MEAs) and Innovative Medicine Access
Policy Brief Issue 26: Rare diseases – Talk of the Town for Some Time but What’s Next?
Policy Brief Issue 25: South Korea’s Experience of Reimbursing High-Cost Medicines
Policy Brief Issue 24: Experience in Using HTA for Expanding UHC Benefit Package to Cover Rare Diseases and High-Cost Drugs among Seven Middle and High-Income Countries: A targeted literature review
Policy Brief Issue 23: Learning from Cancer Drug Fund (CDF) in England: A special reimbursement pathway for high-cost cancer drugs
Policy Brief Issue 22: Horizon Scanning in the European Union
Policy Brief Issue 21: The Life Saving Drug Program: Australia’s pathway to high-cost drugs
โครงการประเมินเทคโนโลยีและนโยบายด้านสุขภาพ ชั้น 6 อาคาร 6 กรมอนามัย กระทรวงสาธารณสุข ถ.ติวานนท์ อ.เมือง จ.นนทบุรี 11000
โทร : +662-590-4549 , +662-590-4374-5
โทรสาร : +662-590-4369
E-mail : [email protected]
Expanding access to high-cost medicines under the Universal Health Coverage scheme in Thailand: review of current practices and recommendations